Sildenafil and its Maker and Big Pharma: A Risky Investment?

The outlook of companies tied to flagship online pharmacy drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the loss of exclusivity in key markets has introduced substantial uncertainty . Investors are now facing the conseque

read more